Your are here: Home // Posts Tagged With rosiglitazone
From Canada: The Unethical Diabetes Drug Rosiglitazone (Avandia) Should Be Pulled As Soon As Possible
From Canada: The Unethical Diabetes Drug Rosiglitazone (Avandia) Should Be Pulled As Soon As Possible
From the latest research, the type 2 diabetes drug rosiglitazone (Avandia®) is identified as unethical drug and should be pulled in each country around the world. The foundation also concludes that the 34 sites clinical trial in Canada needs to be suspended. The decision should be done as soon as...
Growing Safety Concerns about Diabetes Drugs
Growing Safety Concerns about Diabetes Drugs & its Unethical Trials
Dr. David Juurlink, the chief of clinical pharmacology and toxicology at Sunnybrook Health Sciences Center (in Toronto) has urgred FDA to halt the continuing drug trial for diabetes drug rosiglitazone (aka Avandia) as resaerch has proved it as a factor enhancing the proability of cardiovascular diseases in users 30% more than its...
Tags: Avandia, diabetes drugs, Diabetes News, drug trials, drugs, fda, news, rosiglitazone, Thiazolidinediones, trials
